These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4536423)

  • 41. [Incidence in the past decade of nephrotic syndrome in childhood Therapeutic result of the use of 3 corticosteroids].
    Bosco Borghesan A; Cutaja I; Maringhini S
    Minerva Pediatr; 1980 Aug; 32(15):939-42. PubMed ID: 7464745
    [No Abstract]   [Full Text] [Related]  

  • 42. Chronic nephrotoxicity limits successful use of Tacrolimus in the management of adult steroid-dependent minimal change disease.
    Ramachandran R; Kumar D A P; Nada R; Jha V; Gupta KL; Kohli HS
    Nephrology (Carlton); 2015 May; 20(5):384-5. PubMed ID: 25872662
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
    Podracká L; Böör A; Sasinka M
    Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Follow-up of children with nephrotic syndrome in the light of our material].
    Derulska D; Wojnarowski M
    Pediatr Pol; 1969 Sep; 44(9):1129-34. PubMed ID: 5364500
    [No Abstract]   [Full Text] [Related]  

  • 45. Long term prognosis of the nephrotic syndrome in childhood.
    Schärer K; Minges U
    Clin Nephrol; 1973; 1(3):182-7. PubMed ID: 4783717
    [No Abstract]   [Full Text] [Related]  

  • 46. Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.
    Sabry A; El-Husseini A; El-Dahshan K; Sobh M
    Iran J Kidney Dis; 2009 Jul; 3(3):127-35. PubMed ID: 19617660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclophosphamide for minimal-change nephropathy in children.
    N Engl J Med; 1984 Jul; 311(2):126-7. PubMed ID: 6738594
    [No Abstract]   [Full Text] [Related]  

  • 48. [Therapy of the nephrotic syndrome in children].
    Linneweh F
    Minerva Med; 1973 Oct; 64(76):4007-9. PubMed ID: 4764071
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical and epidemiological data of nephrotic syndrome in Japan].
    Ohno I
    Nihon Rinsho; 2002 Jan; 60 Suppl 1():471-8. PubMed ID: 11838155
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of nephrotic syndrome.
    Gulati S; Kher V; Elhence R; Kumar P; Sharma RK; Gupta A
    Indian Pediatr; 1994 Feb; 31(2):165-70. PubMed ID: 7875840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary nephrotic syndrome in the elderly.
    Ponticelli C; Passerini P; Como G; Melis P; Viganò E; Pozzi C; Altieri P
    Contrib Nephrol; 1993; 105():33-7. PubMed ID: 8252869
    [No Abstract]   [Full Text] [Related]  

  • 52. Blood pressure in children with minimal change nephrotic syndrome during oedema and after steroid therapy: the influence of familial essential hypertension.
    Kontchou LM; Liccioli G; Pela I
    Kidney Blood Press Res; 2009; 32(4):258-62. PubMed ID: 19752575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Serum immunoglobulin level in children with nephrotic syndrome treated with cyclophosphamide].
    Fydryk J
    Pediatr Pol; 1974 Jun; 49(6):679-85. PubMed ID: 4839775
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical and epidemiological data of nephrotic syndrome in Japan].
    Shibasaki T; Ohno I; Ishimoto F
    Nihon Rinsho; 1993 Jan; 51 Suppl():409-20. PubMed ID: 8459570
    [No Abstract]   [Full Text] [Related]  

  • 55. Depression of normal lymphocyte transformation by sera of patients with minimal change nephropathy and other forms of nephrotic syndrome.
    Taube D; Chapman S; Brown Z; Williams DG
    Clin Nephrol; 1981 Jun; 15(6):286-90. PubMed ID: 7249426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The predominance of membranoproliferative glomerulonephritis in childhood nephrotic syndrome in Ibadan, Nigeria.
    Asinobi AO; Gbadegesin RA; Adeyemo AA; Akang EE; Arowolo FA; Abiola OA; Osinusi K
    West Afr J Med; 1999; 18(3):203-6. PubMed ID: 10593158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prognosis of nephrosis].
    Habib R; Kleinknecht C; Gubler MC; Levy M; Guillot M; Gagnadoux MF; Broyer M
    Bol Med Hosp Infant Mex; 1981; 38(3):447-55. PubMed ID: 7271976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The nephrotic syndrome. Its incidence and implications for the community.
    Schlesinger ER; Sultz HA; Mosher WE; Feldman JG
    Am J Dis Child; 1968 Dec; 116(6):623-32. PubMed ID: 5697193
    [No Abstract]   [Full Text] [Related]  

  • 59. The rarity of minimal change disease in Nigerian patients with the nephrotic syndrome.
    Kadiri S; Osobamiro O; Ogunniyi J
    Afr J Med Med Sci; 1993 Dec; 22(4):29-34. PubMed ID: 7839926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Steroid-responsive relapsing nephrotic syndrome associated with early diabetic glomerulopathy in a child.
    Peces R; Riera JR; López Larrea C; Alvarez J
    Nephron; 1987; 46(1):78-82. PubMed ID: 3600916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.